Abstract
Changes in expression and dysfunctional signaling of TrkA/B/C receptors and oncogenic Trk fusion proteins are found in neurological diseases and cancers. Here, we describe the development of a first F-18-labeled optimized lead suitable for in vivo imaging of Trk, [F-18]TRACK, which is radiosynthesized with ease from a nonactivated aryl precursor concurrently combining largely reduced P-gp liability and improved brain kinetics compared to previous leads while displaying high on-target affinity and human kinome selectivity.
Dokumententyp: | Zeitschriftenartikel |
---|---|
Fakultät: | Medizin |
Themengebiete: | 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin und Gesundheit |
ISSN: | 0022-2623 |
Sprache: | Englisch |
Dokumenten ID: | 63184 |
Datum der Veröffentlichung auf Open Access LMU: | 19. Jul. 2019, 12:12 |
Letzte Änderungen: | 04. Nov. 2020, 13:41 |